Searched for
CIPLA TAX CASE
Cipla gets Rs 773 crore demand notice from I-T departmentThe additional demand was raised for disallowances related to deduction of profits and gains derived from the business of developing, maint...- DRL, Cipla can outperform in the near term: Hemang JaniI think maybe because of this news you might see some action in the RBL Bank but I do not really think that there is a case for too much of...
- Given severe under-performance, Indian market more likely to move up after Budget: Sandip Sabharwal“The critical point for Tata Motors always was that the operating leverage is so huge that once the turnaround happens and if it sustains, ...
- Buy Cipla, target price Rs 523: Nirmal BangTthe brokerage has downward revised its FY21 and FY22 forecasts on Cipla, having knocked off Voltaren sales number and pushed Albuterol inh...
- Free pharma samples come under GST lensThe executives have to frequent the city to record statements or make submissions before authorities.
- Pharmaceutical companies offering freebies may come under GST lensThe tax heads of firms such as Novartis India, Sun Pharma, Cipla, Lupin have been summoned for meetings with tax officials, they said.
- Taxman seeks reversal of Cenvat credit on financial investments by companiesTax experts said previous rulings allowed companies to have a combined Cenvat credit. However, there were also some rulings that allowed su...
- Sensex rises after 5 days, Nifty50 reclaims 10,100; IT, pharma stocks rallyShort covering in IT and pharma stocks on weak rupee led to the indices close on a positive note.
- NPPA lens on five pharma companies for Hepatitis C drug overchargeNPPA has sent show-cause notices to these companies alleging overcharging for the combination drug used to treat the potentially fatal Hepa...
- Stay away from mid-caps for the time being: Abhimanyu Sofat, IIFLThough there is a hope of reduction in taxation and direct tax reforms, the weekend statement is getting a lot of HNI community worried, sa...
- Bullish on selective midcap names: Gaurang Shah, Geojit BNP ParibasThe biggest play is going to be over a longer period of time all those Indian corporates who have ventured into the defence after the polic...
- Taxmen to chase errant firms on fear of missing the targetThe CBDT has set a target of Rs 2.56 trillion for Mumbai region, the largest tax region which contributes over a third of the total tax rev...
- Sensex ends 479 points up; Nifty above 8,330; ONGC surges 8%The Sensex ended the day at 27,490.59; up 479.28 points. The broader 50-share Nifty closed the session at 8,331.95; up 150.45 points.
- Sensex ends 297 points down, Nifty above 8,300; Infosys cracks 6% post Q4The S&P BSE Sensex ended the day at 27,437.94; down 297.08 points. The broader 50-share Nifty closed the session at 8,305.25; down 93.05 po...
- Cipla under income tax authorities' scannerMumbai based pharmaceutical giant Cipla came under the scanner of the income tax authorities for alleged tax evasion.
- Pharma companies like Sun Pharma, Dr Reddy's likely to post 15% profit growth in Q3 FY'14Pharmaceutical companies are expected to post core profit growth of over 15 per cent, year-on-year, for the quarter ended December 2013.
- Ten stocks in focus in Wednesday morning tradeIndian markets are likely to trade in a range. Here is a list of ten stocks which are likely to remain in focus in morning trade.
- Query corner: TaxVaibhav Sankla, Executive Director, Adroit helps with your tax planning.
- Sikkim turns into a pharma hubSikkim, which is the least populous state in the country and the second-smallest after Goa, has already attracted pharma investment upwards...
- Drug cos seek cure for R&D ,in the forthcoming budgetIndia’s pharmaceutical industry, which is troubled by the appreciating rupee and market challenges abroad, is hoping that the finance minis...
Load More
